Updated information on the pharmacovigilance obligations imposed on the MAH

Updated information on the pharmacovigilance reporting obligations of the marketing authorization holders and the implementation of the SPC and PIL wording recommendations of the Pharmacovigilance Working Party are published under Pharmacovigilance menu of the website of National Institute of Pharmacy.

Last updated: 2012.01.26 10:41
National Institute for Quality- and Organizational Development in Healthcare and Medicines
National Institute of Pharmacy
| H-1051 Budapest, Zrínyi u. 3. | Mail: 1372 P.O. Box: 450.
Tel: +36 1 88 69 -300 | Fax: +36 1 88 69-460 | Contact | Impressum | Sitemap | Copyright

Opening hours for docketing: Monday to Thursday: 8.30-12.00, Friday: 8.30-11.00